- Home
- MLGO vs FATE Comparison
MLGO vs FATE Comparison
Compare MLGO & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- FATE
- Stock Information
- Founded
- MLGO 2018
- FATE 2007
- Country
- MLGO China
- FATE United States
- Employees
- MLGO N/A
- FATE N/A
- Industry
- MLGO EDP Services
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MLGO Technology
- FATE Health Care
- Exchange
- MLGO Nasdaq
- FATE Nasdaq
- Market Cap
- MLGO 32.4M
- FATE 133.0M
- IPO Year
- MLGO N/A
- FATE 2013
- Fundamental
- Price
- MLGO $1.46
- FATE $1.21
- Analyst Decision
- MLGO
- FATE Hold
- Analyst Count
- MLGO 0
- FATE 8
- Target Price
- MLGO N/A
- FATE $4.14
- AVG Volume (30 Days)
- MLGO 42.2M
- FATE 1.8M
- Earning Date
- MLGO 06-10-2025
- FATE 05-13-2025
- Dividend Yield
- MLGO N/A
- FATE N/A
- EPS Growth
- MLGO N/A
- FATE N/A
- EPS
- MLGO 0.55
- FATE N/A
- Revenue
- MLGO $74,185,505.00
- FATE $13,335,000.00
- Revenue This Year
- MLGO N/A
- FATE N/A
- Revenue Next Year
- MLGO N/A
- FATE N/A
- P/E Ratio
- MLGO $2.67
- FATE N/A
- Revenue Growth
- MLGO N/A
- FATE 105.85
- 52 Week Low
- MLGO $1.11
- FATE $0.66
- 52 Week High
- MLGO $509.60
- FATE $5.92
- Technical
- Relative Strength Index (RSI)
- MLGO 34.76
- FATE 53.44
- Support Level
- MLGO $1.17
- FATE $1.12
- Resistance Level
- MLGO $1.75
- FATE $1.38
- Average True Range (ATR)
- MLGO 0.57
- FATE 0.12
- MACD
- MLGO 0.26
- FATE 0.01
- Stochastic Oscillator
- MLGO 12.55
- FATE 62.22
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.